Frontier Capital Management CO LLC Agios Pharmaceuticals, Inc. Transaction History

Frontier Capital Management CO LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Oct 30, 2018	SELL	$71.67 - $91.95 $1.94 Million - $2.49 Million	-27,037 Closed	0 $0
Q2 2018 Aug 03, 2018	SELL	$73.22 - $99.55 $9.45 Million - $12.9 Million	-129,104 Reduced 82.68%	27,037 $2.28 Million
Q1 2018 Apr 30, 2018	BUY	$59.83 - $86.53 $9.34 Million - $13.5 Million	156,141 New	156,141 $12.8 Million

207

60M

365K

457K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $2.36B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Frontier Capital Management CO LLC, based on Form 13F filings with the SEC.

Stay updated on Frontier Capital Management CO LLC with notifications on news.